Presentations we supply
- Tablet 40 mg
- Tablet 80 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for OsimertinibReference information
Summarised from the product information for Tagrisso. Always follow the product information approved in your own country.
- Active substance
- Osimertinib
- Pharmacotherapeutic group
- Antineoplastic agents, protein kinase inhibitors (ATC code L01EB04)
- Authorised uses
- Adjuvant treatment after complete resection of stage IB to IIIA EGFR-mutation non-small cell lung cancer (NSCLC), adults
- Locally advanced, unresectable EGFR-mutation NSCLC after platinum-based chemoradiation, adults
- First-line treatment of locally advanced or metastatic NSCLC with activating EGFR mutations
- Locally advanced or metastatic EGFR T790M mutation-positive NSCLC, adults
- First-line advanced EGFR-mutation NSCLC, with pemetrexed and platinum-based chemotherapy, adults
- Storage (unopened)
- No special storage conditions.
- Shelf life (unopened)
- 3 years
- Container and pack
- Al/Al perforated unit-dose blisters; cartons of 28 × 1 or 30 × 1 tablets
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Tagrisso: www.ema.europa.eu